Clinical trial · Interventional
Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
Efficacy of Auricular Acupuncture Therapy Via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy(CIPN) in Breast Cancer
NCT07092111CI-TRIAL-00092731unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Auricular acupuncture treatment | Device | — | UNRESOLVED |
| Sham acupuncture group | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Auricular acupuncture treatment group
- description
- On the basis of conventional nursing, patients are treated with bilateral auricular acupuncture points (Seirin Pyonex Needles φ 0.2 mm × 1.2 mm) before chemotherapy. Specific operation: 1 treatment before each chemotherapy treatment, and 2 treatments a week in the 2nd and 3rd weeks of the chemotherapy interval. The patient was instructed to press the acupuncture point for 3 times/d, the pressure time was 5min, and the local swelling pain was tolerated by the patient. The doctor took the needle out for the patient after leaving it for 3 days. Treatment was continued for 4 cycles of chemotherapy, followed up for 2 months after treatment completion, and routine care was carried out during treatment.
- interventionNames
- Device: Auricular acupuncture treatment
- type
- SHAM_COMPARATOR
- label
- Sham acupuncture group
- description
- The treatment regimen is the same as that of the auricular acupuncture treatment group, but with a sham acupuncture (Seirin Pyonex Needles).
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with breast cancer diagnosed with stage I-III; * Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months; * 18 years old≤ age≤ 75 years old, female; * Subjects voluntarily participate in this trial and sign the informed consent form. Exclusion Criteria: * Patients who have had acupuncture treatment in the past; * After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture. * Platelets\< 50,000/μL; * Patients with CIPN≥1 grade 1 (NCI-CTCAE); * Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.
References
Publications (0)
Data not yet available
No reference posted for this study.